Assaf Segal
Amministratore Delegato presso CLAL BIOTECHNOLOGY INDUSTRIES LTD.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Ofer Gonen | M | 50 |
Clal Biotechnology Industries Ltd. (Venture Capital)
 Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel.
CLAL Application Center Ltd.
Clal Life Sciences (CLS) LP
 Clal Life Sciences (CLS) LP Investment ManagersFinance Part of Clal Biotechnology Industries Ltd., Clal Life Sciences (CLS) LP is a venture capital fund.
Campus Bio Management Ltd.
 Campus Bio Management Ltd. Pharmaceuticals: MajorHealth Technology Campus Bio Management Ltd. engages in the development of biopharmaceuticals and medical devices licensed from academic institutes for cancer and inflammatory diseases. The company was founded in May 2008 and is headquartered in Tel Aviv, Israel.
The Hebrew University of Jerusalem
| 26 anni |
| Neil J. Hayward | M | - |
eXIthera Pharmaceuticals, Inc.
 eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | 12 anni |
| Ofer Goldberg | M | 52 |
Clal Biotechnology Industries Ltd. (Venture Capital)
Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel.
FDNA, Inc.
 FDNA, Inc. Packaged SoftwareTechnology Services FDNA, Inc. develops phenotype applications. The private company is based in Boston, MA.
The Hebrew University of Jerusalem
| 20 anni |
| Amnon Peled | M | - |
Biokine Therapeutics Ltd.
 Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | 24 anni |
| Megan Filoon | F | - | 1 anni | |
| Liat Nissan | F | 46 |
Clal Biotechnology Industries Ltd. (Venture Capital)
Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | - |
| Gad Keren | M | 73 |
Clal Biotechnology Industries Ltd. (Venture Capital)
Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | 4 anni |
| Samuel Rubinstein | M | 60 | 11 anni | |
| Yuval Yanai | M | 71 |
Clal Biotechnology Industries Ltd. (Venture Capital)
Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | 9 anni |
| Nufar Malovani | F | 46 |
Clal Biotechnology Industries Ltd. (Venture Capital)
Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | 7 anni |
| Dov Reichman | M | 66 |
Polyheal Ltd.
 Polyheal Ltd. Pharmaceuticals: MajorHealth Technology Polyheal Ltd. provides wound healing products. The company was founded by Vladimir Ritter and Dov Reichman in 1996 and is headquartered in Yavne, Israel. | 28 anni |
| Eyal Kolka | M | - |
Pi-Cardia Ltd.
 Pi-Cardia Ltd. Medical SpecialtiesHealth Technology Pi-Cardia Ltd. develops catheter for the treatment of aortic stenosis. Its technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. The company was founded by Eyal Kolka and Erez Golan in 2009 and is headquartered in Rehovot, Israel. | 15 anni |
| Frans Stassen | M | - |
eXIthera Pharmaceuticals, Inc.
eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | - |
| Homi Shamir | M | 70 | 2 anni | |
| Yekaterina Chudnovsky | F | 39 | 2 anni | |
| David Fox | M | 66 | 4 anni | |
| Erez Golan | M | 63 |
Pi-Cardia Ltd.
Pi-Cardia Ltd. Medical SpecialtiesHealth Technology Pi-Cardia Ltd. develops catheter for the treatment of aortic stenosis. Its technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. The company was founded by Eyal Kolka and Erez Golan in 2009 and is headquartered in Rehovot, Israel. | 15 anni |
| Karen Wilson | F | 61 | 1 anni | |
| William H. Koster | M | 79 |
eXIthera Pharmaceuticals, Inc.
eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | - |
| Avraham Matityahu Fischer | M | 67 |
Clal Biotechnology Industries Ltd. (Venture Capital)
Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | 21 anni |
| Sigalia Heifetz | F | 62 |
Clal Biotechnology Industries Ltd. (Venture Capital)
Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | 12 anni |
| Tomer Efraim Babai | M | 39 |
Clal Biotechnology Industries Ltd. (Venture Capital)
Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | 7 anni |
| Brian Piekos | M | 49 | 1 anni | |
| Menahem Oron | M | - |
Polyheal Ltd.
Polyheal Ltd. Pharmaceuticals: MajorHealth Technology Polyheal Ltd. provides wound healing products. The company was founded by Vladimir Ritter and Dov Reichman in 1996 and is headquartered in Yavne, Israel. | - |
| Adi Ben-Nun | M | - |
The Hebrew University of Jerusalem
| 30 anni |
| Shimon Shitrit | M | 78 |
The Hebrew University of Jerusalem
| 28 anni |
| H. Laurence Shaw | M | - |
Biokine Therapeutics Ltd.
Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | - |
| Eugene Kandel | M | - |
The Hebrew University of Jerusalem
| 27 anni |
| Anthony Michael Stanton | M | 67 |
Biokine Therapeutics Ltd.
Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | - |
| Amnon Alon | M | - |
Variance Economic Consulting Ltd.
 Variance Economic Consulting Ltd. Investment ManagersFinance Variance Economic Consulting Ltd. engages in the provision of financial, economic, and business consulting services. Its services include economic consulting for financial reporting purposes, project financing, and expert opinion. The company was founded by Ram Levy in 2002 and is headquartered in Tel Aviv, Israel. | 18 anni |
| Robert Snyder | M | 75 | 1 anni | |
| Aya Ben-Yakov | M | - | 1 anni | |
| Hani Luxenburg | F | 52 | 1 anni | |
| Yitzhak Meyuhas | M | - |
Biokine Therapeutics Ltd.
Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | - |
| Iris Sadeh | F | - | 12 anni | |
| Gabriel Barbash | M | 74 | 21 anni | |
| Gil Bianco | M | 72 |
Pi-Cardia Ltd.
Pi-Cardia Ltd. Medical SpecialtiesHealth Technology Pi-Cardia Ltd. develops catheter for the treatment of aortic stenosis. Its technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. The company was founded by Eyal Kolka and Erez Golan in 2009 and is headquartered in Rehovot, Israel. | - |
| Paul Wotton | M | 63 |
eXIthera Pharmaceuticals, Inc.
eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | - |
| Barry J. Wolfenson | M | 57 | 1 anni | |
| Scott Yaphe | M | - |
eXIthera Pharmaceuticals, Inc.
eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | 10 anni |
| Antoine Papiernik | M | 56 |
Pi-Cardia Ltd.
Pi-Cardia Ltd. Medical SpecialtiesHealth Technology Pi-Cardia Ltd. develops catheter for the treatment of aortic stenosis. Its technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. The company was founded by Eyal Kolka and Erez Golan in 2009 and is headquartered in Rehovot, Israel. | - |
| Jacques R. Séguin | M | - |
Pi-Cardia Ltd.
Pi-Cardia Ltd. Medical SpecialtiesHealth Technology Pi-Cardia Ltd. develops catheter for the treatment of aortic stenosis. Its technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. The company was founded by Eyal Kolka and Erez Golan in 2009 and is headquartered in Rehovot, Israel. | 5 anni |
| Robert Connelly | M | 63 |
Clal Biotechnology Industries Ltd. (Venture Capital)
Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | - |
| Jacky Govrin-Yehudain | M | - |
Polyheal Ltd.
Polyheal Ltd. Pharmaceuticals: MajorHealth Technology Polyheal Ltd. provides wound healing products. The company was founded by Vladimir Ritter and Dov Reichman in 1996 and is headquartered in Yavne, Israel. | - |
| Fred Meyer | M | - |
eXIthera Pharmaceuticals, Inc.
eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | - |
| Arnon Aharon | M | 55 | 2 anni | |
| Shmuel Cabilly | M | 74 |
Biokine Therapeutics Ltd.
Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | - |
| Moshe Vidman | M | 80 |
The Hebrew University of Jerusalem
| 29 anni |
| Yaron Ilan | M | 64 |
The Hebrew University of Jerusalem
| 26 anni |
| Jonathan Eilat | M | - | - | |
| Robert Ruffolo | M | 74 |
eXIthera Pharmaceuticals, Inc.
eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | - |
| Abraham Israeli | M | 70 |
The Hebrew University of Jerusalem
| 28 anni |
| Joshua Hazenfratz | M | 70 | 17 anni | |
| Erik Feingold | M | - |
FDNA, Inc.
FDNA, Inc. Packaged SoftwareTechnology Services FDNA, Inc. develops phenotype applications. The private company is based in Boston, MA. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Ofra Yamin | F | 61 | 20 anni | |
| Andy David | M | - |
The Hebrew University of Jerusalem
| 6 anni |
| Ariel Shamir | M | - |
The Hebrew University of Jerusalem
| 10 anni |
| Aharon Yaari | M | 72 | 2 anni | |
| Arie Yaakov Peretz | M | 49 |
The Hebrew University of Jerusalem
| 9 anni |
| Ruben Krupik | M | 72 |
Clal Biotechnology Industries Ltd. (Venture Capital)
Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | 12 anni |
| Itzik Ben Eliezer | M | 53 |
The Hebrew University of Jerusalem
| 7 anni |
| Shai Shimon Cohen | M | 56 |
The Hebrew University of Jerusalem
| 7 anni |
| Shiran Manor | F | - | 7 anni | |
| Asaf Pasternak | M | 52 |
The Hebrew University of Jerusalem
| 8 anni |
| Ravit Avidor | F | - |
The Hebrew University of Jerusalem
| 4 anni |
| Gili Elkin | F | - |
The Hebrew University of Jerusalem
| 4 anni |
| Bari Bar Zion | M | 59 |
The Hebrew University of Jerusalem
| 8 anni |
| Yousef Salem Mohammad Najajreh | M | - |
The Hebrew University of Jerusalem
| 6 anni |
| Gideon Schmerling | M | 53 |
The Hebrew University of Jerusalem
| 9 anni |
| Laura Lande-Diner | M | - |
The Hebrew University of Jerusalem
| 9 anni |
| David Gordon | M | - |
The Hebrew University of Jerusalem
| 7 anni |
| Ofer Nargassi | M | 53 |
The Hebrew University of Jerusalem
| 6 anni |
| Dan Weintraub | M | 60 |
The Hebrew University of Jerusalem
| 6 anni |
| Ran Cohen | M | 56 |
The Hebrew University of Jerusalem
| 6 anni |
| Ilan Shwartszorgen | M | 51 |
The Hebrew University of Jerusalem
| 6 anni |
| Shai Babad | M | 47 |
The Hebrew University of Jerusalem
| 4 anni |
| Samuel Moed | M | 62 | - | |
| Hadas Peker-Nir | F | - |
The Hebrew University of Jerusalem
| 13 anni |
| Galit Assaf Shenhar | F | 49 |
The Hebrew University of Jerusalem
| 8 anni |
| Zvi Karcz | M | 57 |
The Hebrew University of Jerusalem
| 7 anni |
| Aharon Schwartz | M | 80 | 10 anni | |
| Dafna Ravid Barzily | F | 60 |
The Hebrew University of Jerusalem
| 7 anni |
| Oded Hermoni | M | - |
The Hebrew University of Jerusalem
| 6 anni |
| Gal Cohen | M | 51 | 13 anni | |
| Assaf Zomet | M | - |
The Hebrew University of Jerusalem
| 6 anni |
| Alona Weiss | M | - |
The Hebrew University of Jerusalem
| 11 anni |
| Shmoulik Barashi | M | 61 |
The Hebrew University of Jerusalem
| 7 anni |
| Asaf Givati | M | 53 |
The Hebrew University of Jerusalem
| 7 anni |
| Ariel Shenhar | M | 58 |
The Hebrew University of Jerusalem
| 7 anni |
| Julian Adams | M | 69 |
Clal Biotechnology Industries Ltd. (Venture Capital)
Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | - |
| Oded Nagar | M | 55 |
The Hebrew University of Jerusalem
| 5 anni |
| Isaac Benbenisti | M | 60 |
The Hebrew University of Jerusalem
| 6 anni |
| Amir Nachlieli | M | 57 |
The Hebrew University of Jerusalem
| 4 anni |
| Yadin Antebi | M | 53 |
The Hebrew University of Jerusalem
| 7 anni |
| Boaz Gur-Lavie | M | 50 | 4 anni | |
| Yoram Cohen | M | 58 |
The Hebrew University of Jerusalem
| 6 anni |
| Joseph Israel | M | 53 |
The Hebrew University of Jerusalem
| 7 anni |
| Gideon Soesman | M | 53 |
The Hebrew University of Jerusalem
| 3 anni |
| Jonathan James Klahr | M | - |
The Hebrew University of Jerusalem
| 2 anni |
| Yacov Nimkovsky | M | 54 |
The Hebrew University of Jerusalem
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Israele | 87 | 87.00% |
| Stati Uniti | 24 | 24.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Assaf Segal
- Contatti personali
